Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?
Saved in:
| Main Authors: | Konstantinos Kostikas, Christos Kyriakopoulos, Athena Gogali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | COPD |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2021.1998410 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologics in COPD: The Road is Still Long and Winding
by: Konstantinos Kostikas, et al.
Published: (2025-05-01) -
Proposal for a 4-Level Classification System of Severe COPD Exacerbation According to Healthcare Resource Utilization
by: Georgios Hillas, et al.
Published: (2024-12-01) -
Real World Study on the Reasons for eScalation or de-Escalation of Inhaled ThEraPies in COPD Patients: the STEPINCOPD Multicenter Observational Study
by: Argyris Tzouvelekis, et al.
Published: (2024-12-01) -
Oscillometry Assesses Small Airway Disease and Reveals Peripheral Lung Pathology in Early Pulmonary Fibrosis: A Cross-Sectional Study
by: Athena Gogali, et al.
Published: (2024-12-01) -
2025 GOLD Report: What is New and What is Noteworthy for the Practicing Clinician
by: Konstantinos Kostikas, et al.
Published: (2025-01-01)